000			01494 a2200385 4500
005			20250517181815.0
264		0	_c20180608
008			201806s 0 0 eng d
022			_a1532-1924
024	7		_a10.1016/j.beha.2017.07.005 _2doi
040			_aNLM _beng _cNLM
100	1		_aInbar, Tsofia
245	0	0	_aWhich patients should I transplant with acute lymphoblastic leukemia? _h[electronic resource]
260			_bBest practice & research. Clinical haematology _c09 2017
300			_a249-260 p. _bdigital
500			_aPublication Type: Journal Article; Review
650	0	4	_aAntibodies, Bispecific _xtherapeutic use
650	0	4	_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use
650	0	4	_aClinical Trials as Topic
650	0	4	_aCombined Modality Therapy _xmethods
650	0	4	_aGraft vs Leukemia Effect
650	0	4	_aHematopoietic Stem Cell Transplantation
650	0	4	_aHumans
650	0	4	_aPhiladelphia Chromosome
650	0	4	_aPrecursor Cell Lymphoblastic Leukemia-Lymphoma _ximmunology
650	0	4	_aProtein Kinase Inhibitors _xtherapeutic use
650	0	4	_aRemission Induction
650	0	4	_aRisk Factors
650	0	4	_aSurvival Analysis
650	0	4	_aTransplantation, Homologous
700	1		_aRowe, Jacob M
700	1		_aHorowitz, Netanel A
773	0		_tBest practice & research. Clinical haematology _gvol. 30 _gno. 3 _gp. 249-260
856	4	0	_uhttps://doi.org/10.1016/j.beha.2017.07.005 _zAvailable from publisher's website
999			_c27703104 _d27703104